Covid-19, FDA and Vaccine
Digest more
The US Food and Drug Administration will now require Covid-19 vaccines from Pfizer/BioNTech and Moderna to use expanded warning labels with more information about the risk of a rare heart condition after vaccination.
No, this is not true. Vaccines undergo rigorous safety testing and are continuously monitored for adverse events.
The CDC began recommending Ixchiq last year for adults traveling to countries where chikungunya is common. The vaccine uses a live, weakened form of the virus to trigger immunity.
The approval applies to anyone aged 18 and older who has a risk of being exposed to the virus. But the FDA and the Centers for Disease Control and Prevention (CDC) released a safety notice on May 9 recommending that adults over 60 years old pause use of the vaccine due to fatal complications.
3d
Econostrum on MSNNovavax Vaccine Gets FDA Approval—But With Strict New RulesUS regulators grant full approval to Novavax shot but sharply limit eligibility. New studies on heart risks required, raising concerns over future vaccine access. The US Food and Drug Administration (FDA) has given full approval to Novavax’s Covid-19 vaccine,
6d
Travel + Leisure on MSNCDC Issues Advisory for Dengue Fever in Mexico and 19 Other Countries—Here’s What It Means"Dengue can become severe within a few hours," the advisory states. "Severe dengue is a medical emergency, usually requiring hospitalization." The full list of countries in the ad
Placebo testing has been part of the process since the 1940s. It’s unclear what additional measures would achieve — but it may slow development.